Melinda E. Sanders

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Brian D. Lehmann, Joshua A. Bauer, Xi Chen et al. · Journal of Clinical Investigation · 2011 · 5.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

Francesca Finotello, Clemens Mayer, Christina Plattner et al. · Genome Medicine · 2019 · 1.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Brian D. Lehmann, Bojana Jovanović, Xi Chen et al. · PLoS ONE · 2016 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +17

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

Suhas Vasaikar, Chen Huang, Xiaojing Wang et al. · Cell · 2019 · 848 citations · Full text

Medicine, Molecular Biology, Oncology +12

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko et al. · Cell Metabolism · 2017 · 646 citations · Full text

Medicine, Cell Biology, Oncology +12